Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer
NCT ID: NCT01956331
Last Updated: 2013-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
302 participants
OBSERVATIONAL
2009-03-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Post-operative morbidity at 30-day :
Post operative complications occurred during 30 days post surgery, evaluated with CTCAE V3.0, and Complications grade 2.3.4 will be analyzed from day 1, at day 20 up to day 30.
Evaluation :
Pre operative : Day -30 to Day 0, Post operative : Day 10, Day 30, Day 90, Day 360.
Secondary outcome :
Post-operative mortality, Length of post operative hospital stay, Length of intensive care unit stay, QOL assessment, One year survival.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lung tumour of clinical staging I to IIIB receiving curative lung resection
Exclusion Criteria
* psychological conditions, social support or geographical conditions not allowing the study follow up
* Pre operative chemotherapy or radiotherapy
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Francais De Pneumo-Cancerologie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LECAER HERVE, MD
Role: STUDY_DIRECTOR
HOPITAL DE DRAGUIGNAN - SERVICE DE PNEUMOLOGIE
CHOUAID CHRISTOS, PR
Role: STUDY_DIRECTOR
HOPITAL INTERCOMMUNAL DE CRETEIL SERVICE DE PNEUMOLOGIE
RAYNAUD Christine, MD
Role: PRINCIPAL_INVESTIGATOR
CENTRE HOSPITALIER D'ARGENTEUIL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier D Argenteuil
Argenteuil, Val D'oise, France
Site 12
Aix-en-Provence, , France
Centre Hospitalier Universitaire
Angers, , France
Centre Hospitalier du Morvan
Brest, , France
Centre François Baclesse
Caen, , France
Centre Hospitalier René Dubos
Cergy-Pontoise, , France
Site 30
Charleville-Mézières, , France
Site 33
Créteil, , France
Site 07
Draguignan, , France
Site 32
Elbeuf, , France
Site 04
Gap, , France
Centre Hospitalier Les Oudairies
La Roche-sur-Yon, , France
Site 41
Le Chesnay, , France
Hospital du Cluzeau
Limoges, , France
Centre Hospitalier Régional
Longjumeau, , France
Site 06
Marseille, , France
Site 42
Orléans, , France
Hospital Saint Antoine
Paris, , France
Site 19
Périgueux, , France
Site 20
Rennes, , France
Site 18
Rouen, , France
Site 17
Rouen, , France
Hôpital Yves Le Foll
Saint-Brieuc, , France
Site 14
Toulon, , France
Site 11
Villefranche-sur-Saône, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFPC 08-05
Identifier Type: -
Identifier Source: org_study_id